WARSAW, Ind., April 29, 2011 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced the launch of the next generation of its Wallis® Posterior Dynamic Stabilization System, the UniWallis™System, in Europe and Asia Pacific. Since the debut of the Wallis System in 2000, feedback collected from surgeons revealed the need for a device that maintains all of the clinical advantages of the Wallis System, provides improved ease of use and offers a more anatomy-sparing procedure.
The principles of the UniWallis and Wallis implants are the same: the spacer controls movements in extension and the band controls movements in flexion. In addition to the advantages it shares with the Wallis implant, the UniWallis implant offers surgeons the ability to perform surgery from a unilateral approach, preserving the supraspinous ligament.
“The launch of the new UniWallis System offers surgeons a redesigned and reinforced approach to increasing patient mobility,” said Steve Healy, President of Zimmer Spine. “The broad array of implant sizes available with the UniWallis System allows us to improve the lives of an even wider range of patients.”
Interspinous dynamic stabilization first appeared in 1987, establishing the need for posterior dynamic stabilization to treat lower back pain due to degenerative instability. Today, the UniWallis implant combines all of the advantages of the originalWallis device but permits even more preservation and adaptability to the patient’s anatomy. The UniWallis System has not received clearance from the Food and Drug Administration and is not available for sale in the United States.
A global leader in medical devices, orthopaedic implants, and spine surgery innovation, Zimmer Spine works with surgeons to improve range of motion and enhance the quality of life for patients with back pain, neck pain, degenerative disc conditions and spine injuries due to trauma. For more information, visit www.zimmerspine.com.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2010 sales were approximately$4.2 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management’s beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and “seeks” or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.